MCLA-117, a CLEC12AxCD3 bispecific antibody targeting a leukaemic stem cell antigen, induces T cell-mediated AML blast lysis
SourceExpert Opinion on Biological Therapy, 19, 7, (2019), pp. 721-733
Article / Letter to editor
Display more detailsDisplay less details
Expert Opinion on Biological Therapy
SubjectAll institutes and research themes of the Radboud University Medical Center; Radboudumc 2: Cancer development and immune defence RIMLS: Radboud Institute for Molecular Life Sciences
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.